Sponsor or institution
Clinical trials and research at Pai Life Sciences, INC.
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $2.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
TLR4-based mucosal melanoma immunotherapy formuation study
A new immune-activating treatment using a TLR4 agonist is being studied to boost anti-tumor responses in mucosal melanoma.
-
A Vaccine for Lymphatic Filariasis (LFGuard) for Adults
A new LF vaccine (LFGuard) aims to help adults in at-risk regions by preventing infection and supporting current mass drug administration efforts.
-
A vaccine to prevent lymphatic filariasis
This study is working on a new vaccine to help protect people from lymphatic filariasis, a disease caused by parasitic worms that affects many around the world, and it aims to provide lasting protection alongside current treatments.
-
Developing a vaccine to prevent urogenital schistosomiasis
This study is testing a new vaccine to help prevent urogenital schistosomiasis, a disease caused by parasitic worms that can lead to serious health problems, and it's looking for participants to help see how well it works and if it's safe for different groups of people.
-
Development of a new vaccine for schistosomiasis
This study is testing a new vaccine called SchistoShield® to help protect people from schistosomiasis, a disease caused by parasites that affects many around the world, and it's designed to be safer and more effective than current treatments that aren't working as well anymore.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.